ANGUS Chemical Company, a leading global manufacturer and marketer of specialty and fine chemicals, announced the appointment of Dave Neuberger as chief executive officer (CEO), effective 15 January 2018. Neuberger succeeds Mark Henning, who will step down as CEO.
Neuberger is an industry veteran with 20 years of experience. He has held a variety of leadership roles with leading chemicals companies. He joins ANGUS after a decade with Ashland Inc., a global specialty chemicals company, where he most recently served as group vice president of the company’s Pharmaceutical, Agriculture and Nutrition Specialties business. In that role, Neuberger oversaw Ashland’s most profitable P&L, and he managed a pipeline of new product introductions. During his time at Ashland, Neuberger also led the company’s North American Industrial Specialties business, including all commercial, technical service and supply chain functions.
“Dave’s track record of building, growing and managing specialty chemicals businesses make him the ideal person to lead ANGUS into its next chapter. Dave has decades of diverse leadership experience across the chemicals industry, as well as a strong, results-driven approach that will immediately create value and position ANGUS for future growth opportunities. We appreciate Mark’s decades of service to ANGUS and are particularly grateful for his stewardship of the company during the carve-out from the Dow Chemical Company. We look forward to working with Dave as we continue to grow the business,” said Robert Kirby, chairman of the ANGUS Board of Directors.
“It is a privilege to join a company of ANGUS’ caliber and work alongside the talented ANGUS management team. ANGUS has an impressive customer base across a variety of end markets, and I am excited to support the company’s mission to empower customers through science and technology and help steer ANGUS into its next phase,” said Neuberger.
Rajeev Amara, a managing director at Golden Gate Capital and ANGUS Board member, added, “We are pleased to welcome Dave to the ANGUS team. This is an exciting moment in the company’s history: ANGUS is the only vertically-integrated global provider of many of the foundational chemicals used in the production of next-generation medicine, including biologics and cell therapy, and we are confident that Dave’s experience and expertise in those sectors will significantly accelerate the company’s growth.”
Prior to Ashland, Neuberger spent nearly a decade at W.R. Grace, where he most recently served as manager of New Business Development at the company’s specialty chemicals and materials division. He earned an MBA in Finance from the University of Pennsylvania, where he was a Palmer Scholar and a BS in Chemical Engineering from Johns Hopkins University.